BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 12469911)

  • 21. Cloning and characterization of a calcium-sensing receptor from the hypercalcemic New Zealand white rabbit reveals unaltered responsiveness to extracellular calcium.
    Butters RR; Chattopadhyay N; Nielsen P; Smith CP; Mithal A; Kifor O; Bai M; Quinn S; Goldsmith P; Hurwitz S; Krapcho K; Busby J; Brown EM
    J Bone Miner Res; 1997 Apr; 12(4):568-79. PubMed ID: 9101368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe hypercalcemia in a 9-year-old Brazilian girl due to a novel inactivating mutation of the calcium-sensing receptor.
    Miyashiro K; Kunii I; Manna TD; de Menezes Filho HC; Damiani D; Setian N; Hauache OM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):5936-41. PubMed ID: 15579740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation (L174R) in the Ca2+-sensing receptor gene associated with familial hypocalciuric hypercalcemia.
    Ward BK; Stuckey BG; Gutteridge DH; Laing NG; Pullan PT; Ratajczak T
    Hum Mutat; 1997; 10(3):233-5. PubMed ID: 9298824
    [No Abstract]   [Full Text] [Related]  

  • 24. Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation.
    Cetani F; Pardi E; Borsari S; Tonacchera M; Morabito E; Pinchera A; Marcocci C; Dipollina G
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):199-206. PubMed ID: 12580936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene.
    Aida K; Koishi S; Inoue M; Nakazato M; Tawata M; Onaya T
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2594-8. PubMed ID: 7673400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia.
    Hirai H; Nakajima S; Miyauchi A; Nishimura K; Shimizu N; Shima M; Michigami T; Ozono K; Okada S
    J Hum Genet; 2001; 46(1):41-4. PubMed ID: 11289719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and clinical analysis of a neonatal severe hyperparathyroidism case caused by a stop mutation in the calcium-sensing receptor extracellular domain representing in effect a human 'knockout'.
    Ward DT; Mughal MZ; Ranieri M; Dvorak-Ewell MM; Valenti G; Riccardi D
    Eur J Endocrinol; 2013 Jul; 169(1):K1-7. PubMed ID: 23612447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy.
    Sanders JL; Chattopadhyay N; Kifor O; Yamaguchi T; Brown EM
    Biochem Biophys Res Commun; 2000 Mar; 269(2):427-32. PubMed ID: 10708570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium metabolism and endocrine functions in a family with familial hypocalciuric hypercalcemia.
    Speer G; Tóth M; Niller HH; Salamon D; Takács I; Miheller P; Patócs A; Nagy Z; Bajnok E; Nyiri P; Lakatos P
    Exp Clin Endocrinol Diabetes; 2003 Dec; 111(8):486-90. PubMed ID: 14714270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism.
    Kobayashi M; Tanaka H; Tsuzuki K; Tsuyuki M; Igaki H; Ichinose Y; Aya K; Nishioka N; Seino Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2716-9. PubMed ID: 9253359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism.
    Ward BK; Magno AL; Davis EA; Hanyaloglu AC; Stuckey BG; Burrows M; Eidne KA; Charles AK; Ratajczak T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3721-30. PubMed ID: 15292296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Familial hypocalciuric hypercalcemia].
    Tóth M; Speer G; Patócs A; Salamon D; Lakatos P; Rácz K; Tulassay Z
    Orv Hetil; 2003 Oct; 144(41):2029-31. PubMed ID: 14631896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia.
    D'Souza-Li L; Yang B; Canaff L; Bai M; Hanley DA; Bastepe M; Salisbury SR; Brown EM; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1309-18. PubMed ID: 11889203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor.
    Nagase T; Murakami T; Tsukada T; Kitamura R; Chikatsu N; Takeo H; Takata N; Yasuda H; Fukumoto S; Tanaka Y; Nagata N; Yamaguchi K; Akatsu T; Yamamoto M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2681-7. PubMed ID: 12050233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of calcium-sensing receptor gene by avian parathyroid gland in vivo: relationship to plasma calcium.
    Yarden N; Lavelin I; Genina O; Hurwitz S; Diaz R; Brown EM; Pines M
    Gen Comp Endocrinol; 2000 Feb; 117(2):173-81. PubMed ID: 10642439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial benign hypocalciuric hypercalcemia.
    Fuleihan Gel-H
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N51-6. PubMed ID: 12412778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia.
    Rajala MM; Klee GG; Heath H
    J Bone Miner Res; 1991 Feb; 6(2):117-24. PubMed ID: 2028833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone mineral density in patients with familial hypocalciuric hypercalcaemia (FHH).
    Abugassa S; Nordenström J; Järhult J
    Eur J Surg; 1992 Aug; 158(8):397-402. PubMed ID: 1356477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor.
    Watanabe T; Bai M; Lane CR; Matsumoto S; Minamitani K; Minagawa M; Niimi H; Brown EM; Yasuda T
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2497-502. PubMed ID: 9661634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.